Valuation: LanZhou Foci Pharmaceutical Co.,Ltd.

Market Cap 3.94B 584M 507M 472M 434M 819M 55.71B 831M 5.57B 2.18B 27.74B 2.19B 2.14B 93B P/E 2024
65.6x
P/E 2025 89.6x
Enterprise Value 3.46B 513M 446M 415M 381M 719M 48.94B 730M 4.89B 1.92B 24.37B 1.93B 1.88B 81.7B EV / Sales 2024
3.66x
EV / Sales 2025 4.3x
Free-Float
34.06%
Yield 2024
0.16%
Yield 2025 0.23%
1 day+0.78%
1 week+3.49%
1 month+13.36%
3 months-7.99%
6 months-12.27%
Current year-10.65%
1 week 7.41
Extreme 7.41
7.86
1 month 7.03
Extreme 7.03
8.07
Current year 6.63
Extreme 6.63
11.02
1 year 6.63
Extreme 6.63
11.02
3 years 5.84
Extreme 5.84
11.85
5 years 5.84
Extreme 5.84
15.17
10 years 5.84
Extreme 5.84
15.17
Manager TitleAgeSince
Chief Executive Officer 62 06/04/2022
Director of Finance/CFO - 02/12/2022
Corporate Officer/Principal 52 01/02/2018
Director TitleAgeSince
Chairman 60 08/05/2014
Chairman 62 30/06/2017
Director/Board Member 54 12/04/2016
Change 5-day change 1-year change 3-year change Capi.($)
+0.78%+3.49%-27.03%-32.87% 584M
+0.21%+3.65%-5.74%-1.80% 13.96B
+0.15%+5.03%-26.87%-48.42% 5.34B
-1.12%+7.35%+5.85%+11.70% 5.16B
+1.56%+2.99%+4.07%-32.30% 4.18B
-0.03%+4.59%+2.96%-2.25% 3.79B
-0.33%+0.68%-0.04%+1.86% 3.66B
+1.51%+2.28%-1.65%+14.25% 3.57B
+0.90%+2.07%-13.36%-22.67% 2.46B
-2.04%+4.97%+0.88%+51.02% 1.92B
Average +0.16%+1.97%-6.09%-6.15% 4.46B
Weighted average by Cap. +0.16%+2.64%-4.89%-6.42%

Financials

2024 2025
Net sales 980M 145M 126M 117M 108M 204M 13.85B 207M 1.38B 543M 6.9B 545M 533M 23.13B 916M 136M 118M 110M 101M 190M 12.94B 193M 1.29B 507M 6.44B 509M 498M 21.6B
Net income 60.07M 8.89M 7.73M 7.2M 6.61M 12.48M 849M 12.67M 84.82M 33.29M 423M 33.4M 32.66M 1.42B 49.21M 7.28M 6.33M 5.89M 5.41M 10.22M 695M 10.38M 69.48M 27.27M 346M 27.36M 26.76M 1.16B
Net Debt -357M -52.87M -45.96M -42.78M -39.27M -74.16M -5.05B -75.31M -504M -198M -2.51B -199M -194M -8.42B -479M -70.91M -61.64M -57.38M -52.68M -99.48M -6.77B -101M -676M -265M -3.37B -266M -260M -11.3B
Logo LanZhou Foci Pharmaceutical Co.,Ltd.
Lanzhou Foci Pharmaceutical Co Ltd is a China-based company mainly engaged in the manufacture of traditional Chinese medicine. The Company's main businesses include the research and development, production and sales of Chinese patent medicines and health products, cultivation and sales of Chinese medicinal materials, processing and sales of Chinese herbal medicines, production and sales of medical devices such as protective masks, and others. The Company's products include Fufang Huangqi Jianpi Oral Liquid, Liuwei Dihuang Pills, Xiaoyao Pills, Xiangsha Yangwei Pills, Shenrong Guben Huanshao Pills, donkey-hide gelatin, Chinese herbal medicine slices, and others. The Company's products cover categories and fields such as tonic, cold, gastrointestinal, gynecology, and tranquilizing sleep.
Employees
1,332
Date Price Change Volume
31/07/26 CN¥7.720 +0.78% 4,480,000
30/07/26 CN¥7.660 -0.65% 4,804,000
29/07/26 CN¥7.710 -0.52% 3,917,050
28/07/26 CN¥7.750 +0.39% 3,913,700
27/07/26 CN¥7.720 +3.49% 4,897,900
  1. Stock Market
  2. Stocks
  3. 002644 Stock